// App-Quantinova.ai

16943 : Abnormal Immunomodulatory Function of Mesenchymal Stem Cells From Elderly Patients With Coronary Artery Disease: A Novel Pro-Atherogenic Mechanism?

Researchers

Presenter

  • Dominique Shum-Tim

Principal Investigators

  • Maximillien Lora

  • Jonathan Afilalo

  • Ines Colmegna

Medical Centers

  • McGill, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Coronary Artery Disease

Biomarkers

  • Mesenchymal stem cells

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • adaptive

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved